Literature DB >> 9683641

FGF signaling in skeletal development.

M C Naski1, D M Ornitz.   

Abstract

The fibroblast growth factor receptor family consists of four receptor tyrosine kinases which bind with varying affinity and specificity to a family of at least fifteen polypeptide ligands. The receptors and ligands perform many essential functions during growth, development and repair. Recent discoveries show that a growing number of skeletal abnormalities result from mutations in the fibroblast growth factor receptors. These findings have led to a greater understanding of the role of fibroblast growth factor signaling during skeletogenesis and have focused research interests on the effects of fibroblast growth factors on endochondral and intramembranous bone development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683641     DOI: 10.2741/a321

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  53 in total

1.  Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.

Authors:  K Yu; D M Ornitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Structural interactions of fibroblast growth factor receptor with its ligands.

Authors:  D J Stauber; A D DiGabriele; W A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.

Authors:  G Venkataraman; R Raman; V Sasisekharan; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways.

Authors:  Y R Hadari; N Gotoh; H Kouhara; I Lax; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 5.  Epithelial mesenchymal interactions, the ECM and limb development.

Authors:  Peter Lonai
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

6.  A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes.

Authors:  M K Hajihosseini; S Wilson; L De Moerlooze; C Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 7.  Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.

Authors:  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

Review 8.  FGF receptor inhibitors: role in cancer therapy.

Authors:  Gennaro Daniele; Jesus Corral; L Rhoda Molife; Johann S de Bono
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

9.  Epithelial-specific requirement of FGFR2 signaling during tooth and palate development.

Authors:  Ryoichi Hosokawa; Xuemei Deng; Kazunori Takamori; Xun Xu; Mark Urata; Pablo Bringas; Yang Chai
Journal:  J Exp Zool B Mol Dev Evol       Date:  2009-06-15       Impact factor: 2.656

10.  FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.

Authors:  Takayuki Nakayama; Noriko Mutsuga; Giovanna Tosato
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.